Core Viewpoint - The strategic cooperation agreement between He Eye Hospital and Johnson & Johnson Vision Care aims to enhance cataract diagnosis and treatment technologies, dry eye services, and talent development in the ophthalmology field [1][2]. Group 1: Strategic Cooperation - He Eye Hospital and Johnson & Johnson Vision Care will collaborate on advancing clinical applications of new ophthalmic technologies and products, focusing on cataract treatment, advanced medical equipment promotion, presbyopia development, and clinical skill enhancement for young and mid-career doctors [1]. - The partnership will accelerate the introduction of innovative ophthalmic products and technologies in the Chinese market, including the Smart Preloaded Intraocular Lens, Catalys 7.0 femtosecond laser treatment machine, Veritas ultrasound emulsification device, and Elita femtosecond laser corneal refractive surgery equipment [1]. Group 2: Goals and Vision - The collaboration is expected to drive the Chinese refractive cataract surgery into a new era of intelligence, providing patients with a globally advanced treatment experience and contributing to the long-term development of eye health under the "Healthy China" strategy [2]. - The partnership will leverage Johnson & Johnson Vision Care's global perspective, innovation capabilities, and talent development experience to promote cutting-edge ophthalmic technologies, high-end equipment, and personalized services widely in China [2].
何氏眼科与强生眼力健签署战略合作协议 共建老视诊疗手术亚太卓越中心